Hedge Fund - DAFNA Capital Management
Blueprint Medicines Corp (BPMC)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2024 - Q2 (2024-06-30) | $11,291,356 | 2.69% | 104,763 | $100.09 |
2 | 2024 - Q1 (2024-03-31) | $10,127,538 | 2.3% | 106,763 | $85.76 |
3 | 2023 - Q4 (2023-12-31) | $10,226,003 | 2.45% | 110,863 | $64.79 |
4 | 2023 - Q3 (2023-09-30) | $12,530,945 | 3.89% | 249,521 | $53.44 |
5 | 2023 - Q2 (2023-06-30) | $15,896,127 | 4.34% | 251,521 | $54.36 |
6 | 2023 - Q1 (2023-03-31) | $11,752,963 | 3.52% | 261,235 | $45.05 |
7 | 2022 - Q4 (2022-12-31) | $11,444,705 | 3.22% | 261,235 | $47.96 |
8 | 2022 - Q3 (2022-09-30) | $17,213,000 | 4.62% | 261,235 | $64.23 |
9 | 2022 - Q2 (2022-06-30) | $13,197,000 | 3.59% | 261,280 | $58.58 |
10 | 2022 - Q1 (2022-03-31) | $15,732,000 | 4.09% | 246,280 | $71.78 |
11 | 2021 - Q4 (2021-12-31) | $22,162,000 | 5.57% | 206,911 | $104.60 |
12 | 2021 - Q3 (2021-09-30) | $21,273,000 | 5.64% | 206,911 | $93.12 |
13 | 2021 - Q2 (2021-06-30) | $18,288,000 | 3.82% | 207,911 | $91.63 |
14 | 2021 - Q1 (2021-03-31) | $20,215,000 | 4.79% | 207,911 | $99.84 |
15 | 2020 - Q4 (2020-12-31) | $23,205,000 | 6.9% | 206,911 | $105.38 |
16 | 2020 - Q3 (2020-09-30) | $21,607,000 | 7.02% | 233,089 | $77.01 |
17 | 2020 - Q2 (2020-06-30) | $17,791,000 | 5.13% | 228,089 | $67.64 |
18 | 2020 - Q1 (2020-03-31) | $13,339,000 | 5.56% | 228,089 | $64.35 |
19 | 2019 - Q4 (2019-12-31) | $9,871,000 | 3.38% | 123,218 | $74.87 |
20 | 2019 - Q3 (2019-09-30) | $9,053,000 | 3.4% | 123,218 | $86.44 |
21 | 2019 - Q2 (2019-06-30) | $11,623,000 | 4.36% | 123,218 | $82.54 |
22 | 2019 - Q1 (2019-03-31) | $9,583,000 | 4.13% | 119,718 | $73.89 |
23 | 2018 - Q4 (2018-12-31) | $4,997,000 | 2.48% | 92,691 | $60.78 |
24 | 2018 - Q3 (2018-09-30) | $7,235,000 | 2.97% | 92,691 | $69.50 |
25 | 2018 - Q2 (2018-06-30) | $5,884,000 | 2.75% | 92,691 | $79.58 |
26 | 2018 - Q1 (2018-03-31) | $8,133,000 | 3.95% | 88,691 | $86.20 |
27 | 2017 - Q4 (2017-12-31) | $7,593,000 | 4.08% | 100,691 | $70.36 |
28 | 2017 - Q3 (2017-09-30) | $5,295,000 | 3.28% | 76,000 | $53.44 |
29 | 2017 - Q2 (2017-06-30) | $4,155,000 | 2.96% | 82,000 | $42.46 |
30 | 2017 - Q1 (2017-03-31) | $3,299,000 | 2.79% | 82,500 | $35.81 |
31 | 2016 - Q4 (2016-12-31) | $2,034,000 | 1.78% | 72,500 | $30.14 |
32 | 2016 - Q2 (2016-06-30) | $205,000 | 0.16% | 10,100 | $18.17 |
The displayed share prices are average quarterly stock market prices.